Abstract 2888: Lipid nanoparticle-mediated delivery of siRNA to extrahepatic tumors
Joseph P. Davide(United States Military Academy), Weikang Tao(Shanghai Medical Information Center), Laura Sepp‐Lorenzino(Intellia Therapeutics (United States)), Jerome Hochman(United States Military Academy), Bin Shi(Fujian Medical University), Manishkumar Patel(Merck & Co., Inc., Rahway, NJ, USA (United States)), James J. Cunningham(Merck & Co., Inc., Rahway, NJ, USA (United States)), Bruce Ng(United States Military Academy), Xianzhi Mao(United States Military Academy)
Cited by 0
Related Papers
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
|New England Journal of Medicine|2021|1.7k
Total Synthesis of Spirotryprostatin A, Leading to the Discovery of Some Biologically Promising Analogues
|Journal of the American Chemical Society|1999|463
Pharmacologic shifting of a balance between protein refolding and degradation mediated by Hsp90
|Proceedings of the National Academy of Sciences|1996|409
A peptidomimetic inhibitor of farnesyl:protein transferase blocks the anchorage-dependent and -independent growth of human tumor cell lines.
|PubMed|1995|385
Micro RNA 145 Targets the Insulin Receptor Substrate-1 and Inhibits the Growth of Colon Cancer Cells
|Journal of Biological Chemistry|2007|356